LV12188B - APPLICATION OF TRICYCLIC DERIVATIVES OF 1,4-DIHIDRO-1,4-DIOXO-1H-NAFTHALINE TO OBTAIN NEW CONTAINERS AND USE THEM IN THERAPY \ t - Google Patents
APPLICATION OF TRICYCLIC DERIVATIVES OF 1,4-DIHIDRO-1,4-DIOXO-1H-NAFTHALINE TO OBTAIN NEW CONTAINERS AND USE THEM IN THERAPY \ t Download PDFInfo
- Publication number
- LV12188B LV12188B LVP-98-136A LV980136A LV12188B LV 12188 B LV12188 B LV 12188B LV 980136 A LV980136 A LV 980136A LV 12188 B LV12188 B LV 12188B
- Authority
- LV
- Latvia
- Prior art keywords
- dihydro
- dioxo
- thiazole
- naphtho
- new product
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/24—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings
- C07C225/26—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings having amino groups bound to carbon atoms of quinone rings or of condensed ring systems containing quinone rings
- C07C225/30—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings having amino groups bound to carbon atoms of quinone rings or of condensed ring systems containing quinone rings of condensed quinone ring systems formed by two rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C46/00—Preparation of quinones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C50/00—Quinones
- C07C50/24—Quinones containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C50/00—Quinones
- C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
- C07C50/32—Quinones containing groups having oxygen atoms singly bound to carbon atoms the quinoid structure being part of a condensed ring system having two rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/60—Naphthoxazoles; Hydrogenated naphthoxazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/84—Naphthothiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/12—One of the condensed rings being a six-membered aromatic ring the other ring being at least seven-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9514683A FR2742153B1 (fr) | 1995-12-12 | 1995-12-12 | Utilisation de derives tricycliques du 1,4-dihydro-1,4- dioxo-1h-naphtalene, nouveaux composes obtenus et leur application en therapeutique |
| PCT/FR1996/001973 WO1997021684A1 (fr) | 1995-12-12 | 1996-12-10 | Utilisation de derives tricycliques du 1,4-dihydro-1,4-dioxo-1h-naphtalene, nouveaux composes obtenus et leur application en therapeutique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LV12188A LV12188A (lv) | 1998-12-20 |
| LV12188B true LV12188B (en) | 1999-07-20 |
Family
ID=9485393
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LVP-98-136A LV12188B (en) | 1995-12-12 | 1998-06-12 | APPLICATION OF TRICYCLIC DERIVATIVES OF 1,4-DIHIDRO-1,4-DIOXO-1H-NAFTHALINE TO OBTAIN NEW CONTAINERS AND USE THEM IN THERAPY \ t |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6262095B1 (hu) |
| EP (1) | EP0876356B1 (hu) |
| JP (1) | JP2000501724A (hu) |
| KR (1) | KR19990072080A (hu) |
| AP (1) | AP889A (hu) |
| AR (1) | AR005054A1 (hu) |
| AT (1) | ATE207907T1 (hu) |
| AU (1) | AU716199B2 (hu) |
| BR (1) | BR9611935A (hu) |
| CA (1) | CA2240279A1 (hu) |
| CZ (1) | CZ181198A3 (hu) |
| DE (1) | DE69616598D1 (hu) |
| EE (1) | EE9800174A (hu) |
| FR (1) | FR2742153B1 (hu) |
| HU (1) | HUP9901247A3 (hu) |
| ID (1) | ID16081A (hu) |
| IL (1) | IL124558A0 (hu) |
| LT (1) | LT4491B (hu) |
| LV (1) | LV12188B (hu) |
| NO (1) | NO982696L (hu) |
| NZ (1) | NZ323967A (hu) |
| OA (1) | OA10696A (hu) |
| PL (1) | PL327168A1 (hu) |
| RU (1) | RU2178791C2 (hu) |
| TR (1) | TR199801069T2 (hu) |
| WO (1) | WO1997021684A1 (hu) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003999A (en) * | 1997-12-19 | 1999-07-12 | Advanced Research And Technology Institute, Inc. | Modulators of ryanodine receptors comprising 2-(aryl)-4,7-dioxobenzothiazoles and analogues thereof |
| CA2433018A1 (en) * | 2000-12-21 | 2002-06-27 | Joel C. Barrish | Thiazolyl inhibitors of tec family tyrosine kinases |
| TWI402261B (zh) | 2006-06-19 | 2013-07-21 | Takeda Pharmaceutical | 三環化合物及其醫藥組成物 |
| US7754463B2 (en) | 2006-06-20 | 2010-07-13 | Dana-Farber Cancer Institute | Inhibitors of USP1 Deubiquitinating Enzyme Complex |
| WO2011137320A2 (en) | 2010-04-30 | 2011-11-03 | Dana-Farber Cancer Institute, Inc. | Small molecule inhibitors of usp1 deubiquitinating enzyme activity |
| US9040713B2 (en) * | 2010-09-27 | 2015-05-26 | Emory University | Methods of managing blood sugar levels and compositions related thereto |
| US9725425B1 (en) | 2014-02-25 | 2017-08-08 | Dana-Farber Cancer Institute, Inc. | Compounds and methods for treating cancer |
| RU2545091C1 (ru) * | 2014-03-18 | 2015-03-27 | Федеральное государственное бюджетное учреждение "Российский онкологический научный центр имени Н.Н. Блохина" Российской академии медицинских наук (ФГБУ "РОНЦ им. Н.Н. Блохина" РАМН) | 1-R-4,9-ДИОКСО-1H-НАФТО[2,3-d][1,2,3]ТРИАЗОЛ-4-ОКСИМ-2-ОКСИДЫ И ИХ ПРОИЗВОДНЫЕ, ОБЛАДАЮЩИЕ ЦИТОТОКСИЧЕСКОЙ АКТИВНОСТЬЮ |
| US10829427B2 (en) | 2015-12-18 | 2020-11-10 | The Board Of Regents Of The University Of Texas System | Naphthoquinones, pro-drugs, and methods of use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3039925A (en) | 1957-04-24 | 1962-06-19 | Bayer Ag | Compositions for the treatment of tuberculosis |
| US4746676A (en) | 1984-09-12 | 1988-05-24 | Rorer Pharmaceutical Corporation | Carboxyalkyl dipeptide compounds |
| JPH05112533A (ja) * | 1991-05-08 | 1993-05-07 | Upjohn Co:The | イミダゾベンゾキノン類およびこれを有効成分とする高血圧・鬱血性心不全の予防・治療剤 |
-
1995
- 1995-12-12 FR FR9514683A patent/FR2742153B1/fr not_active Expired - Fee Related
-
1996
- 1996-12-10 EP EP96941734A patent/EP0876356B1/fr not_active Expired - Lifetime
- 1996-12-10 IL IL12455896A patent/IL124558A0/xx unknown
- 1996-12-10 AT AT96941734T patent/ATE207907T1/de not_active IP Right Cessation
- 1996-12-10 AP APAP/P/1998/001275A patent/AP889A/en active
- 1996-12-10 RU RU98113147/04A patent/RU2178791C2/ru active
- 1996-12-10 CZ CZ981811A patent/CZ181198A3/cs unknown
- 1996-12-10 KR KR1019980704387A patent/KR19990072080A/ko not_active Application Discontinuation
- 1996-12-10 TR TR1998/01069T patent/TR199801069T2/xx unknown
- 1996-12-10 CA CA002240279A patent/CA2240279A1/fr not_active Abandoned
- 1996-12-10 NZ NZ323967A patent/NZ323967A/en unknown
- 1996-12-10 WO PCT/FR1996/001973 patent/WO1997021684A1/fr not_active Application Discontinuation
- 1996-12-10 BR BR9611935A patent/BR9611935A/pt unknown
- 1996-12-10 DE DE69616598T patent/DE69616598D1/de not_active Expired - Lifetime
- 1996-12-10 AU AU11018/97A patent/AU716199B2/en not_active Ceased
- 1996-12-10 PL PL96327168A patent/PL327168A1/xx unknown
- 1996-12-10 JP JP9521799A patent/JP2000501724A/ja active Pending
- 1996-12-10 EE EE9800174A patent/EE9800174A/xx unknown
- 1996-12-10 HU HU9901247A patent/HUP9901247A3/hu unknown
- 1996-12-10 US US09/043,831 patent/US6262095B1/en not_active Expired - Fee Related
- 1996-12-12 AR ARP960105648A patent/AR005054A1/es unknown
- 1996-12-12 ID IDP963710A patent/ID16081A/id unknown
-
1998
- 1998-06-10 LT LT98-085A patent/LT4491B/lt not_active IP Right Cessation
- 1998-06-11 NO NO982696A patent/NO982696L/no not_active Application Discontinuation
- 1998-06-12 LV LVP-98-136A patent/LV12188B/en unknown
- 1998-06-12 OA OA9800080A patent/OA10696A/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69616598D1 (de) | 2001-12-06 |
| AU716199B2 (en) | 2000-02-24 |
| PL327168A1 (en) | 1998-11-23 |
| IL124558A0 (en) | 1998-12-06 |
| NO982696L (no) | 1998-08-11 |
| FR2742153B1 (fr) | 1998-02-13 |
| WO1997021684A1 (fr) | 1997-06-19 |
| LT4491B (lt) | 1999-04-26 |
| LT98085A (en) | 1998-11-25 |
| NZ323967A (en) | 2000-06-23 |
| AU1101897A (en) | 1997-07-03 |
| LV12188A (lv) | 1998-12-20 |
| HUP9901247A2 (hu) | 1999-08-30 |
| CA2240279A1 (fr) | 1997-06-19 |
| NO982696D0 (no) | 1998-06-11 |
| EE9800174A (et) | 1998-12-15 |
| RU2178791C2 (ru) | 2002-01-27 |
| US6262095B1 (en) | 2001-07-17 |
| ID16081A (id) | 1997-09-04 |
| KR19990072080A (ko) | 1999-09-27 |
| AP889A (en) | 2000-11-17 |
| BR9611935A (pt) | 1999-05-18 |
| FR2742153A1 (fr) | 1997-06-13 |
| HUP9901247A3 (en) | 2000-08-28 |
| OA10696A (fr) | 2002-11-26 |
| CZ181198A3 (cs) | 1998-09-16 |
| AR005054A1 (es) | 1999-04-07 |
| AP9801275A0 (en) | 1998-06-30 |
| EP0876356A1 (fr) | 1998-11-11 |
| ATE207907T1 (de) | 2001-11-15 |
| JP2000501724A (ja) | 2000-02-15 |
| EP0876356B1 (fr) | 2001-10-31 |
| TR199801069T2 (xx) | 1998-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69930120T2 (de) | Annellierte azepinone als inhibitoren cyclin-abhängiger kinasen | |
| JPS61218589A (ja) | ５―（６―イミダゾ〔１，２―ａ〕ピリジニル）ピリジン誘導体 | |
| JP2001504109A (ja) | ベンゾ複素環ジスタマイシン誘導体、それらを製造する方法および抗腫瘍および抗ウイルス剤としてのそれらの用途 | |
| Venkatesh et al. | Design and synthesis of Quinazolinone, Benzothiazole derivatives bearing guanidinopropanoic acid moiety and their Schiff bases as cytotoxic and antimicrobial agents | |
| LV12188B (en) | APPLICATION OF TRICYCLIC DERIVATIVES OF 1,4-DIHIDRO-1,4-DIOXO-1H-NAFTHALINE TO OBTAIN NEW CONTAINERS AND USE THEM IN THERAPY \ t | |
| WO2018214639A1 (zh) | 2-氮杂环-5-三氟甲基-8-硝基苯并(硫代)吡喃-4-酮类化合物及其制备方法和用途 | |
| CA2557942C (fr) | Derives de carbamate de 2h- ou 3h-benzo[e]indazol-1-yle, leur preparation et leur application en therapeutique | |
| CA2513059A1 (fr) | Nouveaux derives d'azepines tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| JP2000502081A (ja) | １，４―ジヒドロ―１，４―ジオキソナフタレンのヘテロ芳香族及び三環式誘導体の利用、得られる新規化合物並びにその治療用途 | |
| KR100755579B1 (ko) | 단백질 티로신 포스파타제 억제제로서디아미노피롤로퀴나졸린 화합물 | |
| CA2481460C (en) | 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics | |
| US5981544A (en) | Mono-- or diketone tetracyclic derivatives and therapeutical uses thereof | |
| JP2013505922A (ja) | 新規アミノ酸誘導体、その製造法、及びｍｅｔファミリーによる発癌性シグナルの阻害剤としてのその治療的使用 | |
| MXPA98004717A (es) | Utilizacion de derivados triciclicos de 1,4-dihidro-1,4-dioxo-1h-naftaleno, nuevos compuestos obtenidos y su aplicacion terapeutica | |
| KR20240110273A (ko) | 새로운 인돌리진-피롤로피리미딘 하이브리드 유도체 제조방법 및 이를 포함하는 항암제 조성물 | |
| DE19947297A1 (de) | Cyclische Biphenyle, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel | |
| JP2009256274A (ja) | ５員複素環化合物を有効成分とする抗ガン剤および新規５員複素環化合物 | |
| DE4311782A1 (de) | Indazol-Derivate und diese enthaltende Arzneimittel | |
| EP0988036A1 (fr) | Utilisation de derives de tetracycles dicetoniques, nouveaux composes obtenus et leur application en therapeutique | |
| MXPA06009859A (en) | 2h or 3h-benzo[e]indazol-1-yle carbamate derivatives, the preparation and therapeutic use thereof |